Replies to post #126 on TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

TCRX: Novartis collaboration news (old news)

https://www.sec.gov/Archives/edgar/data/1783328/000095012321003678/filename3.htm

https://www.biospace.com/article/tscan-and-novartis-partner-to-develop-immune-therapies-for-solid-tumors/

https://www.biopharminternational.com/view/tscan-therapeutics-novartis-collaborate-t-cell-receptor-therapies

Collaboration period ended March 31/23 = 180 day countdown for Novartis to exercise licensing (Sept.28/23 deadline to advise on intent to license/Tscan notice of intent to license to third party)

[crazy horse 0]

TCRX institution holders